Sabra Healthcare REIT (SBC) Stock Forecast & Price Target
3 Followers
SBC Analyst Ratings
Moderate Buy
4Buy5Hold0Sell
Based on 9 analysts giving stock ratings to Sabra Healthcare REIT in the past 3 months
SBC Stock 12 Month Forecast
Average Price Target
EUR 19.13▲(7.03% Upside)Based on 9 Wall Street analysts offering 12 month price targets for Sabra Healthcare REIT in the last 3 months. The average price target is EUR 19.13 with a high forecast of EUR 21.35 and a low forecast of EUR 17.79. The average price target represents a 7.03% change from the last price of EUR 17.87.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 21.35
AverageEUR 19.13
LowEUR 17.79
Highest Price TargetHighestEUR 21.35Average Price TargetEUR 19.13Lowest Price TargetLowestEUR 17.79
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| James Feldman | Wells Fargo | EUR 20.46→EUR 18.68 | buy | 4.54%Upside | Reiterated | 11/03/26 | ||
| Nicholas Yulico | Scotiabank | EUR 17.79 | hold | -0.43%Downside | Reiterated | 11/03/26 | ||
| Richard Hightower | Barclays | EUR 20.46→EUR 18.68 | hold | 4.54%Upside | Reiterated | 10/13/26 | ||
| Michael Goldsmith | UBS | EUR 18.68→EUR 17.79 | hold | -0.43%Downside | Assigned | 10/13/26 | ||
| Robert Stevenson | Janney Montgomery | EUR 20.46 | buy | 14.50%Upside | Initiated | 09/09/26 | ||
| Vikram Malhotra | Mizuho Securities | EUR 17.79→EUR 18.68 | hold | 4.54%Upside | Reiterated | 08/31/26 | ||
| Farrell Granath | Bank of America Securities | ― | buy | ― | Reiterated | 08/17/26 | ||
| Michael Lewis | Truist Financial | EUR 21.35 | buy | 19.48%Upside | Reiterated | 08/13/26 | ||
| Richard Anderson | Cantor Fitzgerald | EUR 19.57 | hold | 9.52%Upside | Reiterated | 08/10/26 | ||
| Dave Rodgers | Raymond James | EUR 20.46 | hold | 14.50%Upside | Upgraded | 08/06/26 | ||
| Aaron Hecht | Citizens JMP | EUR 20.46→EUR 22.24 | buy | 24.46%Upside | Reiterated | 07/22/26 | ||
| Wes Golladay | Robert W. Baird | EUR 19.57→EUR 20.46 | hold | 14.50%Upside | Reiterated | 07/22/26 | ||
| Omotayo Okusanya | Deutsche Bank | EUR 19.57→EUR 22.24 | buy | 24.46%Upside | Reiterated | 07/22/26 | ||
 Seth BergeyNot Ranked | Citi | EUR 21.35→EUR 16.90 | hold | -5.41%Downside | Downgraded | 06/23/26 | ||
| Juan C. Sanabria | BMO Capital | EUR 19.57→EUR 20.46 | hold | 14.50%Upside | Reiterated | 04/29/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| James FeldmanWells Fargo | BuyReiteratedEUR 20.46→EUR 18.68 | 11/03/26 | 4.54%Upside | ||
| Nicholas YulicoScotiabank | HoldReiteratedEUR 17.79 | 11/03/26 | -0.43%Downside | ||
| Richard HightowerBarclays | HoldReiteratedEUR 20.46→EUR 18.68 | 10/13/26 | 4.54%Upside | ||
| Michael GoldsmithUBS | HoldAssignedEUR 18.68→EUR 17.79 | 10/13/26 | -0.43%Downside | ||
| Robert StevensonJanney Montgomery | BuyInitiatedEUR 20.46 | 09/09/26 | 14.50%Upside | ||
| Vikram MalhotraMizuho Securities | HoldReiteratedEUR 17.79→EUR 18.68 | 08/31/26 | 4.54%Upside | ||
| Farrell GranathBank of America Securities | BuyReiterated | 08/17/26 | ― | ||
| Michael LewisTruist Financial | BuyReiteratedEUR 21.35 | 08/13/26 | 19.48%Upside | ||
| Richard AndersonCantor Fitzgerald | HoldReiteratedEUR 19.57 | 08/10/26 | 9.52%Upside | ||
| Dave RodgersRaymond James | HoldUpgradedEUR 20.46 | 08/06/26 | 14.50%Upside | ||
| Aaron HechtCitizens JMP | BuyReiteratedEUR 20.46→EUR 22.24 | 07/22/26 | 24.46%Upside | ||
| Wes GolladayRobert W. Baird | HoldReiteratedEUR 19.57→EUR 20.46 | 07/22/26 | 14.50%Upside | ||
| Omotayo OkusanyaDeutsche Bank | BuyReiteratedEUR 19.57→EUR 22.24 | 07/22/26 | 24.46%Upside | ||
| Seth BergeyCitiNot Ranked | HoldDowngradedEUR 21.35→EUR 16.90 | 06/23/26 | -5.41%Downside | ||
| Juan C. SanabriaBMO Capital | HoldReiteratedEUR 19.57→EUR 20.46 | 04/29/26 | 14.50%Upside |
Stocks with the Highest Top Analyst Consensus in the Real Estate Sector
Best Analysts Covering Sabra Healthcare REIT
3 Months
Success Rate10/17 ratings generated profit
59%
Average Return
+3.92%
Copying Michael Lewis's trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of +3.92% per trade.
1 Year
Success Rate6/10 ratings generated profit
60%
Average Return
+5.77%
Copying Aaron Hecht's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +5.77% per trade.
2 Years
Success Rate13/17 ratings generated profit
76%
Average Return
+22.62%
Copying Michael Lewis's trades and holding each position for 2 Years would result in 76.47% of your transactions generating a profit, with an average return of +22.62% per trade.
SBC Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 8 | 11 | 12 | 7 | 4 |
| Hold | 9 | 11 | 9 | 7 | 3 |
| Sell | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 18 | 23 | 21 | 14 | 7 |
In the current month, SBC has received 4 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. SBC average Analyst price target in the past 3 months is 19.13.
SBC Financial Forecast
HighEUR 0.16
ConsensusEUR 0.15
LowEUR 0.12
SBC Earnings Forecast
Next quarter’s earnings estimate for SBC is EUR 0.15 with a range of EUR 0.12 to EUR 0.16. The previous quarter’s EPS was EUR 0.10. Its overall industry beat the EPS estimate 54.52% of the time in the past 12 months.
HighEUR 232M
ConsensusEUR 219M
LowEUR 211M
SBC Sales Forecast
Next quarter’s sales forecast for SBC is EUR 218.81M with a range of EUR 210.52M to EUR 232.44M. The previous quarter’s sales results were EUR 223.39M. Its overall industry beat sales estimates 73.09% of the time in the past 12 months.
SBC Stock Forecast FAQ
What is DE:SBC’s average 12-month price target, according to analysts?
Based on analyst ratings, Sabra Healthcare REIT’s 12-month average price target is €19.13.
What is DE:SBC’s upside potential, based on the analysts’ average price target?
Sabra Healthcare REIT has 7.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sabra Healthcare REIT a Buy, Sell or Hold?
Sabra Healthcare REIT has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 5 hold ratings and 0 sell ratings.
What is Sabra Healthcare REIT’s share price target?
The average share price target for Sabra Healthcare REIT is €19.13. This is based on 9 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €21.35, and the lowest forecast is €17.79. The average share price target represents a 7.03% increase from the current price of €17.87.
What do analysts say about Sabra Healthcare REIT?
Sabra Healthcare REIT’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Street analysts.
How can I buy shares of Sabra Healthcare REIT?
To buy shares of DE:SBC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
